Actually if you look at historical data you will notice that after each dilution and the initial decline the stock price was at least doubled in 18 months or so.
will be the high for the next 5 years until maturity. That's the cap... See you in 2021.
Still looking to close my short of 13000 shares at $2.5 in the next few weeks.
Thanks everyone. Cha ching!!
Doesn't matter what IMGN does, as soon as the stock price goes up, IMGN management will dilute shareholder's value by issuing more shares. Look at IMGN's historical data.
They could make it much better if we could see the whole comment on the topic board with a mouse rollover and vote it up or down right there too so we don't have to take the time to leave the page unless we want to reply or view replies.
It all comes down to whether 853 succeeds in its P3 for third-line folate positive EOC, and if so, $1.5 to $2B mkt cap would be a low estimate for fair value. It looks comparable to olaparib results in its enriched sub-population so the signal seems to be there; I give it a 75% chance. There are other possible catalysts along the line including combo trials, partner milestones and partner results but FORWARD I is the big one.
CLIS is one that i am watching closley right now. This stock has had some interesting developments and with all the M&A in fantasy sports CLIS could really capitalize. They make a fantasy sports analytics tool that will change the game
They don’t want you to know about Lion Stock Alerts (google them) because these guys are the
real deal. They only alert solid momentum stocks, NO BS…
IMGN management have no ownership in IMGN and uses IMGN as an ATM (withdrawals only). Historical chart shows you each time IMGN gains traction, shareholders value gets diluted with new stocks being issues and in this case new notes issued (IOUs). IMGN management have milked investors capital with false hopes of developing their own drug while their only source of revenue stream is paltry royalties. With the current stock price around $3 and earnings per share -$2, IMGN management have pretty much milked IMGN to the ground. IMGN CEO should be whipped and thrown out of management. If you enjoy making a donation to support extravagant life styles of CEOs, IMGN is for you.
. Instead of sitting around browsing yahoo all day open a new tab with google and search for
UltimateStockAlertss and sign up. Their small cap plays have made me some big money this past
year. Im a follower for life.
This is going to be an overhang for the stock for a little while; whenever shares pop above $4.18, expect some short selling by the entities who own a piece of the ~24mm new shares on offer here since they can essentially cover at $4.18. I think there's potential for a good result from the FDA meeting, a new partnership, or or FORWARD II to lift prices above the $4.18 quagmire.